Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting (Q43836354)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 1991
edit
Language Label Description Also known as
English
Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting
scientific article published in January 1991

    Statements

    Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting (English)
    D M Shin
    P Y Holoye
    W K Murphy
    A Forman
    S C Papasozomenos
    W K Hong
    M Raber
    1 January 1991
    145-149

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit